Literature DB >> 2339683

Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations.

R H Allen1, S P Stabler, D G Savage, J Lindenbaum.   

Abstract

The serum cobalamin assay is the primary diagnostic test for cobalamin deficiency. It appears to be an excellent screening test since most patients with clinically confirmed cobalamin deficiency have low levels. Recent studies indicate that the clinical picture of cobalamin deficiency is much more diverse than previously believed. It is also apparent that many patients with low serum cobalamin concentrations are not cobalamin deficient. Thus, there is a need for additional diagnostic tests to further distinguish patients with low serum cobalamin levels who are actually cobalamin deficient and will benefit from lifetime treatment from those who are not deficient and will not benefit. Serum levels of methylmalonic acid and total homocysteine have been shown to be markedly elevated in most patients with cobalamin deficiency, and total homocysteine concentrations are markedly elevated in most patients with folate deficiency. The levels of these metabolites fall to normal if these patients are treated with the appropriate vitamin but remain essentially unchanged if the wrong vitamin is administered. These observations demonstrate that serum methylmalonic acid and total homocysteine levels are useful in diagnosing patients with cobalamin and folate deficiency and in distinguishing between these two vitamin deficiencies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339683     DOI: 10.1002/ajh.2830340204

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  34 in total

1.  Utility of measuring vitamin B12 and its active fraction, holotranscobalamin, in neurological vitamin B12 deficiency syndromes.

Authors:  Wiebke Schrempf; Marco Eulitz; Volker Neumeister; Gabriele Siegert; Rainer Koch; Heinz Reichmann; Alexander Storch
Journal:  J Neurol       Date:  2010-10-02       Impact factor: 4.849

Review 2.  Potential outcome factors in subacute combined degeneration: review of observational studies.

Authors:  Olavo M Vasconcelos; Erika H Poehm; Robert J McCarter; William W Campbell; Zenaide M N Quezado
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

Review 3.  Multiple sclerosis and vitamin B12 metabolism.

Authors:  E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

Review 4.  Thoughts on B-vitamins and dementia.

Authors:  Martha Clare Morris; Julie A Schneider; Christine C Tangney
Journal:  J Alzheimers Dis       Date:  2006-08       Impact factor: 4.472

Review 5.  Megaloblastic anemia and other causes of macrocytosis.

Authors:  Florence Aslinia; Joseph J Mazza; Steven H Yale
Journal:  Clin Med Res       Date:  2006-09

6.  How I treat cobalamin (vitamin B12) deficiency.

Authors:  Ralph Carmel
Journal:  Blood       Date:  2008-07-07       Impact factor: 22.113

7.  Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers only: a randomized clinical trial in Bangladesh.

Authors:  Towfida J Siddiqua; Shaikh M Ahmad; Khalid B Ahsan; Mamunur Rashid; Anjan Roy; Syed M Rahman; Setareh Shahab-Ferdows; Daniela Hampel; Tahmeed Ahmed; Lindsay H Allen; Rubhana Raqib
Journal:  Eur J Nutr       Date:  2015-02-04       Impact factor: 5.614

Review 8.  Challenges and Lessons Learned in Generating and Interpreting NHANES Nutritional Biomarker Data.

Authors:  Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Clifford L Johnson; Elizabeth A Yetley
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

9.  Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12.

Authors:  Regan L Bailey; Ralph Carmel; Ralph Green; Christine M Pfeiffer; Mary E Cogswell; John D Osterloh; Christopher T Sempos; Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2011-06-15       Impact factor: 7.045

10.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.